Patient Oriented Research in Gastrointestinal Cancer Screening

以患者为导向的胃肠癌筛查研究

• 批准号: 8496765
• 负责人: PHILIP S SCHOENFELD
• 金额: $ 13.34万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8496765
• 关键词: Achievement; Alcohol consumption; Algorithms; Area; Award; Barrett Esophagus; Binding; Biological Markers; Blood; Body mass index; Caliber; Clinic; Clinical; Clinical Protocols; Clinical Research; Colon; Colon Carcinoma; Colonic Adenoma; Colonoscopy; Colorectal Cancer; Confocal Microscopy; Data; Databases; Detection; Development; Diagnosis; Dietary Questionnaires; Dysplasia; Endoscopy; Environment; Epidemiology; Equipment and Supplies; Esophageal Adenocarcinoma; Esophagus; Faculty; Family history of; First Degree Relative; Fluorescence; Funding; Future; Gastrointestinal tract structure; Gender; Genomics; Goals; Grant; Health Services Research; Heme Iron; Human Resources; Hyperplastic Polyp; Image; Individual; Intake; Iron; K-Series Research Career Programs; Label; Lesion; Malignant Neoplasms; Malignant neoplasm of gastrointestinal tract; Measures; Meat; Medical; Medicine; Mentors; Mentorship; Michigan; Mid-Career Clinical Scientist Award (K24); Molecular Weight; Mucous Membrane; National Institute of Diabetes and Digestive and Kidney Diseases; Neoplasms; Non-Steroidal Anti-Inflammatory Agents; Outcomes Research; Participant; Patients; Penetration; Peptides; Performance; Physical activity; Plasma; Practice Management; Prevalence; Principal Investigator; Protocols documentation; Public Health Schools; Publications; Race; Research; Research Design; Research Personnel; Research Project Grants; Resources; Risk; Risk Factors; Screening for cancer; Study Section; Supervision; System; Techniques; Time; Tissue Banking; Tissue Banks; Tobacco use; Topical application; Training; Training Programs; Translational Research; United States National Institutes of Health; Universities; Woman; adenoma; adipokines; career; clinical epidemiology; colorectal cancer screening; high risk; image registration; improved; in vivo; modifiable risk; older patient; optical imaging; patient oriented; patient oriented research; programs; public health relevance; screening; success; tool

DESCRIPTION (provided by applicant): This K24 Mid-Career Investigator Award will facilitate training GI fellows participating in a specialized Training Program in GI Epidemiology (T32-DK062708), mentoring of junior faculty applying for/completing career development awards, and performance of patient-oriented research in GI cancer screening trials funded by NIH and VA. "The best predictor of future success may be past achievement." As principal investigator and Director of the U. of Michigan Training Program in GI Epidemiology, I have successfully mentored 100% of the participants to careers in academic medicine. In our program, GI fellows complete a Master's program in Clinical Research Design and Statistical Analysis and undergo extensive mentoring and supervision from senior investigators which contributes to their successful transition to academic medicine. I also mentor junior faculty on K23, R21, and other career development awards after they complete this training program. In addition to providing protected time to mentor trainees and junior faculty, this grant will also facilitate my research career objective: identification of risk factors for GI cancer and development of more effective tools for GI cancer screening. I have successfully completed K23 and R21 grants which have led to multiple publications. Currently, I am PI of a VA-funded Center grant about the application of family history and genomic tools to improve colorectal cancer (CRC) screening, and co-investigator of a U54 grant developing in vivo biomarkers for the identification of dysplasia in the esophagus and colon during endoscopy. These on-going research projects will provide a platform for trainees and junior faculty to develop their own research. Also, the U. of Michigan provides an outstanding environment and resources, including our specialized Training Program in GI Epidemiology, our NIH-funded Michigan Clinical Research Unit, VA-funded Center of Excellence for Practice Management and Outcomes Research, and our School of Public Health's specialized Master's Programs in Clinical Epidemiology. Unfortunately, mentoring of GI fellows and junior faculty is unfunded. The current U54 and VA funding pay for research supplies, equipment, and ancillary personnel, but provides inadequate funding to protect my time for patient-oriented research and mentorship. This K24 award will provide essential support to achieve my mentorship and research goals. PUBLIC HEALTH RELEVANCE: This award will provide support to mentor young investigators performing patient-oriented GI cancer screening research. It will also provide the candidate to complete studies on this topic. The proposed studies will improve screening techniques for Barrett's esophagus and esophageal adenocarcinoma, facilitate appropriate screening of patients with a family history of colorectal cancer, identify modifiable risk factors for colon adenomas, and identify new tools to detect dysplasia in the gastrointestinal tract.

描述（由申请人提供）：此K24中期职业研究者奖将促进培训GI研究员参加GI流行病学专业培训计划（T32-DK 062708），指导初级教师申请/完成职业发展奖，以及在NIH和VA资助的GI癌症筛查试验中进行以患者为导向的研究。“未来成功的最佳预测者可能是过去的成就。“作为首席研究员和美国国家科学院院长，在密歇根州GI流行病学培训计划中，我成功地指导了100%的参与者从事学术医学。在我们的计划中，GI研究员完成临床研究设计和统计分析硕士课程，并接受高级研究人员的广泛指导和监督，这有助于他们成功过渡到学术医学。我还指导初级教师在K23，R21和其他职业发展奖后，他们完成这个培训计划。除了为指导学员和初级教师提供受保护的时间外，这笔赠款还将促进我的研究职业目标：确定GI癌症的风险因素和开发更有效的GI癌症筛查工具。我已经成功地完成了K23和R21赠款，导致多个出版物。目前，我是VA资助的中心资助的PI，该中心资助了家族史和基因组工具的应用，以改善结直肠癌（CRC）筛查，并共同研究了U 54资助的体内生物标志物，用于在内窥镜检查期间识别食管和结肠的异型增生。这些正在进行的研究项目将为学员和初级教师提供一个平台，以发展自己的研究。此外，美国密歇根大学提供了一个优秀的环境和资源，包括我们的GI流行病学专业培训计划，我们的NIH资助的密歇根临床研究单位，VA资助的实践管理和成果研究卓越中心，以及我们的公共卫生学院的专业硕士临床流行病学课程。不幸的是，对GI研究员和初级教师的指导没有资金。目前的U 54和VA资金支付研究用品，设备和辅助人员，但提供的资金不足，以保护我的时间为导向的研究和指导。这个K24奖将提供必要的支持，以实现我的导师和研究目标。 公共卫生相关性：该奖项将为指导年轻研究人员进行以患者为导向的GI癌症筛查研究提供支持。它还将提供候选人完成对这一主题的研究。拟议的研究将改善Barrett食管和食管腺癌的筛查技术，促进对有结直肠癌家族史的患者进行适当的筛查，确定结肠腺瘤的可改变的风险因素，并确定检测胃肠道发育不良的新工具。